164 filings
8-K
TRIL
Trillium Therapeutics Inc.
17 Nov 21
Pfizer Completes Acquisition of Trillium Therapeutics
9:28am
8-K
TRIL
Trillium Therapeutics Inc.
16 Nov 21
Other Events
5:07pm
8-K
TRIL
Trillium Therapeutics Inc.
29 Oct 21
Trillium Therapeutics Receives Final Court Order Approving Arrangement
6:00am
8-K
TRIL
Trillium Therapeutics Inc.
27 Oct 21
Trillium Securityholders Approve Acquisition by Pfizer
6:00am
8-K
TRIL
Trillium Therapeutics Inc.
20 Oct 21
Other Events
6:03am
8-K
nah8o0 fpg7u
15 Oct 21
Other Events
6:00am
8-K
pn8cgvls w5q24x0c
13 Oct 21
Other Events
8:05am
8-K
w082qiy 1ndkgs3
23 Aug 21
Voting Support Agreement
7:53am
8-K
mo1mbi
13 Aug 21
Trillium Therapeutics Reports Second Quarter 2021 Operating and Financial Results
7:05am
8-K
3wgz nhsi58qh9a6m
30 Jun 21
Trillium Therapeutics Appoints Catherine Mackey, PH.D., to Its Board of Directors
7:00am
8-K
1oh3e7f rs1
9 Jun 21
Trillium Announces Voting Results from the Annual General and Special Meeting of Shareholders
7:01am
8-K
tjmk67shzrpoo7
7 May 21
Trillium Therapeutics Reports First Quarter 2021 Operating and Financial Results
7:02am
8-K
gdpe4kqs z6
28 Apr 21
Results of Operations and Financial Condition
7:04am
8-K
dj7rb0giiznsii1
23 Apr 21
Results of Operations and Financial Condition
7:01am
8-K
9nggdo4
22 Apr 21
Regulation FD Disclosure
7:00am
8-K
03wuqh4j sls2
18 Mar 21
Trillium Therapeutics Reports Annual Operating and Financial Results and Sets Date for R&D Day
4:05pm
6-K
j9ts4cog
7 Dec 20
Trillium Therapeutics Presented Clinical Data at the 62ND Ash Annual Meeting and Provides Guidance for 2021
4:05pm
6-K
4k4auj
25 Nov 20
Trillium Therapeutics to Present Clinical Data at the 62ND American Society of Hematology Annual Meeting
7:03am
6-K
im524y 13
16 Nov 20
Consolidated Financial Statements
7:09am
6-K
m140d4hsjrex
12 Nov 20
Trillium Therapeutics Appoints Paolo Pucci
4:05pm